Clinical remission with biologic therapies in severe asthma: a matter of definition
UK Severe Asthma Registry
UK Severe Asthma Registry
Abstract
There is currently no evidence to support the use of maintenance and reliever therapy (MART) in patients with severe asthma and persistently elevated T2 biomarkers despite adherence to high dose ICS treatment https://bit.ly/42IOVbA
MIDER Authors
Citations
Altmetric:
Date
2024-06-20
Type
Article
Subject
Respiratory medicine
Collections
Citation
UK Severe Asthma Registry; McDowell PJ, McDowell R, Busby J, Eastwood MC, Patel PH, Jackson DJ, Mansur A, Patel M, Burhan H, Doe S, Chaudhuri R, Gore R, Dodd JW, Subramanian D, Brown T, Heaney LG. Clinical remission with biologic therapies in severe asthma: a matter of definition. Eur Respir J. 2024 Jun 20;63(6):2400160. doi: 10.1183/13993003.00160-2024. PMID: 38901893; PMCID: PMC11187314.
Journal / Source Title
European Respiratory Journal
DOI
PMID
Publisher
European Respiratory Society